I agree that this site is using cookies. You can find further informations here.
X
Bertolani, Arianna
42  results:
Search for persons X
?
1

Innovative research methodologies in the EU regulatory fram..:

Giannuzzi, Viviana ; Bertolani, Arianna ; Torretta, Silvia...
Frontiers in Medicine.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Pharmaceutical pricing and managed entry agreements: An exp..:

Jommi, Claudio ; Bertolani, Arianna ; Armeni, Patrizio..
Health Policy and Technology.  12 (2023)  3 - p. 100771 , 2023
Link: https://doi.org/10.1016/..
 
?
3

The costs incurred by patients to get eligibility to PCSK9 ..:

Bertolani, Arianna ; Ravasio, Roberto ; Raimondo, Paola.
Global & Regional Health Technology Assessment.  9 (2022)  - p. 73-81 , 2022
Link: https://doi.org/10.33393..
 
?
4

The costs incurred by patients to get eligibility to PCSK9 ..:

Arianna Bertolani ; Roberto Ravasio ; Paola Raimondo.
https://journals.aboutscience.eu/index.php/grhta/article/view/2415.  , 2022
Link: https://doi.org/10.33393..
 
?
5

Il costo a carico dei pazienti del percorso per eleggibilit..:

Bertolani, Arianna ; Ravasio, Roberto ; Raimondo, Paola.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768598/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Second-Generation Antipsychotic Drugs for Patients with Sch..:

Rognoni, Carla ; Bertolani, Arianna ; Jommi, Claudio
Clinical Drug Investigation.  41 (2021)  4 - p. 303-319 , 2021
Link: https://doi.org/10.1007/..
 
?
7

The future of Funds for Innovative Medicines: results from ..:

Jommi, Claudio ; Armeni, Patrizio ; Bertolani, Arianna..
Global & Regional Health Technology Assessment.  8 (2021)  - p. 22-28 , 2021
Link: https://doi.org/10.33393..
 
?
8

Il futuro dei Fondi per Farmaci Innovativi: risultati di un..:

Jommi, Claudio ; Armeni, Patrizio ; Bertolani, Arianna..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616190/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

The future of Funds for Innovative Medicines: results from ..:

Claudio Jommi ; Patrizio Armeni ; Arianna Bertolani..
https://journals.aboutscience.eu/index.php/grhta/article/view/2219.  , 2021
Link: https://doi.org/10.33393..
 
?
10

Second-generation antipsychotic drugs for patients with sch..:

Rognoni, Carla ; Bertolani, Arianna ; Jommi, Claudio
info:eu-repo/semantics/altIdentifier/wos/WOS:000626350800001.  , 2021
Link: http://hdl.handle.net/11..
 
?
11

The future of Funds for Innovative Medicines: results from ..:

Jommi, Claudio ; Armeni, Patrizio ; Bertolani, Arianna..
info:eu-repo/semantics/altIdentifier/wos/WOS:000628985000001.  , 2021
Link: http://hdl.handle.net/11..
 
?
12

Implementation of Value-based Pricing for Medicines:

Jommi, Claudio ; Armeni, Patrizio ; Costa, Francesco..
Clinical Therapeutics.  42 (2020)  1 - p. 15-24 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Implementation of value-based pricing for medicines:

Jommi, Claudio ; Armeni, Patrizio ; Costa, Francesco..
info:eu-repo/semantics/altIdentifier/wos/WOS:000516654800004.  , 2020
Link: http://hdl.handle.net/11..
 
?
14

La spesa sanitaria: composizione ed evoluzione:

Patrizio Armeni ; Arianna Bertolani ; Ludovica Borsoi.
info:eu-repo/semantics/altIdentifier/isbn/9788823851627.  , 2019
Link: http://hdl.handle.net/11..
 
?
15

The hospitalization burden of influenza just the tip of the..:

Arianna Bertolani ; Giovanni Fattore ; Fabrizio Pregliasco
info:eu-repo/semantics/altIdentifier/wos/WOS:000438066000001.  , 2018
Link: http://hdl.handle.net/24..
 
1-15